vTv Therapeutics Inc (VTVT) — Strategic Asset Allocation Index
vTv Therapeutics Inc (VTVT) has a Strategic Asset Allocation Index of 1930.6% as of March 2023. Strategic assets (PP&E of $185.00K plus long-term investments of $7.69 Million) total $7.88 Million, measured against net assets of $408.00K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See VTVT net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
vTv Therapeutics Inc Strategic Asset Allocation Index (2020–2022)
This chart shows how vTv Therapeutics Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of March 2023, the index stands at 1930.6%, representing strategic assets of $7.88 Million against net assets of $408.00K USD. For live market cap and overall valuation, see VTVT stock market capitalisation.
Annual Strategic Asset Allocation Index for vTv Therapeutics Inc (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for vTv Therapeutics Inc from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See vTv Therapeutics Inc (VTVT) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 99.2% | $5.79 Million | $207.00K | $5.59 Million | $5.84 Million | ▲ +34.5 pp |
| 2021 | 64.7% | $9.85 Million | $680.00K | $9.17 Million | $15.22 Million | ▼ -122.2 pp |
| 2020 | 187.0% | $7.09 Million | $367.00K | $6.72 Million | $3.79 Million | — |